HK1039273A1 - Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient - Google Patents

Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient

Info

Publication number
HK1039273A1
HK1039273A1 HK01108775A HK01108775A HK1039273A1 HK 1039273 A1 HK1039273 A1 HK 1039273A1 HK 01108775 A HK01108775 A HK 01108775A HK 01108775 A HK01108775 A HK 01108775A HK 1039273 A1 HK1039273 A1 HK 1039273A1
Authority
HK
Hong Kong
Prior art keywords
sustained
active ingredient
release pharmaceutical
pharmaceutical preparation
preparation containing
Prior art date
Application number
HK01108775A
Other languages
English (en)
Inventor
Richard Hirsch
Martin Wesseling
Thomas Strungmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of HK1039273A1 publication Critical patent/HK1039273A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HK01108775A 1998-12-23 2001-12-13 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient HK1039273A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859636A DE19859636A1 (de) 1998-12-23 1998-12-23 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
PCT/EP1999/010381 WO2000038656A1 (de) 1998-12-23 1999-12-23 Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff

Publications (1)

Publication Number Publication Date
HK1039273A1 true HK1039273A1 (en) 2002-04-19

Family

ID=7892368

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108775A HK1039273A1 (en) 1998-12-23 2001-12-13 Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient

Country Status (22)

Country Link
US (1) US6579536B1 (xx)
EP (1) EP1140031B1 (xx)
JP (1) JP2002533381A (xx)
AT (1) ATE252377T1 (xx)
AU (1) AU770293B2 (xx)
BR (1) BR9916575A (xx)
CA (1) CA2355891A1 (xx)
CZ (1) CZ301628B6 (xx)
DE (2) DE19859636A1 (xx)
DK (1) DK1140031T3 (xx)
ES (1) ES2207334T3 (xx)
HK (1) HK1039273A1 (xx)
HU (1) HUP0104647A3 (xx)
MX (1) MXPA01006493A (xx)
NO (1) NO320022B1 (xx)
NZ (1) NZ512079A (xx)
PL (1) PL199024B1 (xx)
PT (1) PT1140031E (xx)
SK (1) SK284901B6 (xx)
TR (1) TR200101864T2 (xx)
WO (1) WO2000038656A1 (xx)
ZA (1) ZA200105040B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
PL193273B1 (pl) 1997-12-22 2007-01-31 Euro Celtique Sa Postać dawkowania doustnego
EP1935421A1 (en) * 2000-02-08 2008-06-25 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
CN1423559A (zh) 2000-02-08 2003-06-11 欧罗赛铁克股份有限公司 包含阿片样激动剂和拮抗剂的控释组合物
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
CA2478523A1 (en) 2002-04-05 2003-10-16 Euro-Celtique S.A. Matrix for sustained, invariant and independent release of active compounds
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1771159A4 (en) * 2004-07-22 2009-04-29 Amorepacific Corp SLOW RELEASE PREPARATIONS CONTAINING TOPIRAMATE AND PROCESS FOR PRODUCING THE SAME
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
EP2168945A1 (en) * 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate
EP2448406B1 (en) 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
ES2706407T3 (es) 2009-03-10 2019-03-28 Euro Celtique Sa Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CA2959186C (en) 2014-09-19 2020-03-24 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71847A1 (xx) * 1975-02-14 1977-01-05
CA2147759C (en) * 1992-10-26 2004-08-10 Wolfgang Herrmann Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) * 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
WO1999055662A1 (en) * 1998-04-28 1999-11-04 Russinsky Limited Tilidine mesylate, processes for its preparation and pharmaceutical composition thereof

Also Published As

Publication number Publication date
DE19859636A1 (de) 2000-06-29
CA2355891A1 (en) 2000-07-06
HUP0104647A3 (en) 2003-12-29
PL348419A1 (en) 2002-05-20
NZ512079A (en) 2003-08-29
PT1140031E (pt) 2004-03-31
NO20013060L (no) 2001-06-20
US6579536B1 (en) 2003-06-17
MXPA01006493A (es) 2002-06-04
HUP0104647A2 (hu) 2002-03-28
ES2207334T3 (es) 2004-05-16
DE59907481D1 (de) 2003-11-27
EP1140031B1 (de) 2003-10-22
SK8922001A3 (en) 2001-12-03
DK1140031T3 (da) 2003-12-01
ZA200105040B (en) 2002-05-22
SK284901B6 (sk) 2006-02-02
AU770293B2 (en) 2004-02-19
ATE252377T1 (de) 2003-11-15
AU2286200A (en) 2000-07-31
CZ301628B6 (cs) 2010-05-05
EP1140031A1 (de) 2001-10-10
TR200101864T2 (tr) 2002-01-21
BR9916575A (pt) 2001-09-18
NO20013060D0 (no) 2001-06-20
JP2002533381A (ja) 2002-10-08
CZ20012167A3 (cs) 2001-11-14
PL199024B1 (pl) 2008-08-29
WO2000038656A1 (de) 2000-07-06
NO320022B1 (no) 2005-10-10

Similar Documents

Publication Publication Date Title
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
HUP0100225A3 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
BR0015188A (pt) Composições farmacêuticas
HK1076605A1 (en) Formulations
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
ZA200003702B (en) Beta-carboline compounds, a process for their preparation and pharmaceutical compositions containing them.
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
IL150528A0 (en) Ibuprofen containing active agent preparation
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
AP2001002369A0 (en) Pharmaceutical complex.
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
ZA986800B (en) Oligo-Thiophenes useful as antimetastatic agents, a preparation thereof and pharmaceutical compositions containing them.
UA27784C2 (uk) Шипуча фармацевтична композиція для орального введення
HUP9801085A3 (en) Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
MD20040296A (ro) Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ
MX9606264A (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121223